Skip to content

The Effect of Transcutaneous Electrical Acupoint Stimulation Combined With Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery

The Effect of Transcutaneous Electrical Acupoint Stimulation Combined With Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07045090
Enrollment
116
Registered
2025-07-01
Start date
2024-05-01
Completion date
2024-11-01
Last updated
2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Keywords

Elderly patients, postoperative delirium, gastrointestinal surgery, Auricular vagus nerve stimulation, Transcutaneous electrical acupoint stimulation

Brief summary

The aim of this clinical trial is to study the effect of transcutaneous electrical acupoint stimulation combined with auricular vagus nerve stimulation on postoperative delirium in elderly patients undergoing gastrointestinal surgery. The study aims to answer the following main questions 1. whether it reduces the expression of inflammatory factors in the acute postoperative period 2. whether it can reduce the incidence of postoperative delirium

Detailed description

Existing clinical studies have shown that TEAS has demonstrated value in preventing postoperative delirium (POD). Currently, taVNS is commonly used clinically to improve patients' cognitive dysfunction (POCD), and POD is often considered a precursor to the development of POCD. However, no one has yet used the two in combination, so this study aimed to combine the two to investigate their potential benefits in preventing POD.

Interventions

DEVICETranscutaneous electrical acupoint stimulation

Before induction of anaesthesia, electrodes were attached to selected acupoints and energised for 30 min, with the electrical stimulation parameter of dispersed dense wave (2/100 Hz), and the current intensity was based on the maximum current intensity that could be tolerated by the patient.

DEVICETranscutaneous electrical acupoint stimulation combined with auricular vagus nerve stimulation

Before anaesthesia induction, the electrodes were attached to the selected acupoints and energized for 30 min, with the electrical stimulation parameters of dispersed dense wave (2/100Hz), and the current intensity was based on the maximum current intensity that the patient could tolerate. At the same time, the left ear auricular region was stimulated with a fasciculus nerve stimulator, the electrical stimulation parameters were: pulse width of 250 μs, pulse frequency of 20Hz, every 30s on, 30s off, and then 30s on again, the current intensity was based on the maximum current intensity that the patient could tolerate, for 30min.

Sponsors

Affiliated Hospital of Nantong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged ≥65 years; 2. Body mass index (BMI) 18-30 kg/m²; 3. American Society of Anesthesiologists (ASA) physical status classification I-III; 4. Patients scheduled for elective laparoscopic gastrointestinal surgery; 5. Willingness to provide written informed consent and comply with the treatment regimen; 6. Absence of severe organic diseases, psychiatric disorders, or preoperative delirium.

Exclusion criteria

1. Preoperative Mini-Mental State Examination (MMSE) score \<20; 2. Electrocardiographic evidence of severe bradycardia (heart rate \<50 beats per minute); 3. Presence of skin lesions or infections at the electrical stimulation site; 4. History of preoperative chemotherapy or radiotherapy; 5. Concomitant severe organic diseases with compromised tolerance to interventions; 6. Prior exposure to Transcutaneous Electrical Acupoint Stimulation (TEAS) or transcutaneous auricular vagus nerve stimulation (taVNS) with documented insensitivity; 7. Inability to communicate normally, dementia, hearing impairment, or severe psychiatric disorders.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of postoperative deliriumThe first to third days after surgeryWhether delirium occurred after surgery(by 3D-CAM)

Secondary

MeasureTime frameDescription
IL-6 andTNF-α levelbefore operation(Before anesthesia),the end of the operation(Immediately after the sewing is finished)the level of IL-6 andTNF-α in the participant's serum(by ELISA)
VAS pain scoreThe first to third days after surgeryAssessed with a VAS score scale, the highest is 10 and the lowest is 0, the higher the more severe the pain
Early activitiesPost-operative period until discharge(in about a week)The first time to be able to get out of bed and move
Time to first postoperative anal defecationPost-operative period until discharge(In about a week)Time to first postoperative anal defecation
Adverse eventsThe first to third days after surgeryNausea and vomiting, sore throat, itching

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026